Free Trial

Geode Capital Management LLC Purchases 8,540 Shares of National Health Investors, Inc. (NYSE:NHI)

National Health Investors logo with Finance background

Geode Capital Management LLC boosted its position in National Health Investors, Inc. (NYSE:NHI - Free Report) by 0.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,094,570 shares of the real estate investment trust's stock after buying an additional 8,540 shares during the period. Geode Capital Management LLC owned approximately 2.41% of National Health Investors worth $92,026,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of NHI. Charles Schwab Investment Management Inc. grew its position in shares of National Health Investors by 17.0% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 852,377 shares of the real estate investment trust's stock worth $71,651,000 after buying an additional 123,596 shares during the period. Land & Buildings Investment Management LLC lifted its position in shares of National Health Investors by 4.6% during the 2nd quarter. Land & Buildings Investment Management LLC now owns 417,834 shares of the real estate investment trust's stock valued at $28,300,000 after acquiring an additional 18,232 shares during the period. Zimmer Partners LP bought a new position in National Health Investors during the third quarter worth $25,218,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in National Health Investors by 332.0% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 242,326 shares of the real estate investment trust's stock worth $20,370,000 after purchasing an additional 186,238 shares during the period. Finally, Sound Income Strategies LLC increased its stake in National Health Investors by 10.8% in the third quarter. Sound Income Strategies LLC now owns 169,582 shares of the real estate investment trust's stock valued at $14,255,000 after purchasing an additional 16,463 shares in the last quarter. Institutional investors own 62.51% of the company's stock.

National Health Investors Stock Up 1.5 %

NHI stock traded up $1.01 during mid-day trading on Friday, reaching $69.85. 750,877 shares of the company traded hands, compared to its average volume of 204,402. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92. The firm's 50 day moving average price is $76.18 and its 200 day moving average price is $75.52. The stock has a market cap of $3.17 billion, a price-to-earnings ratio of 24.00, a P/E/G ratio of 4.86 and a beta of 1.04. National Health Investors, Inc. has a fifty-two week low of $51.59 and a fifty-two week high of $86.13.

National Health Investors (NYSE:NHI - Get Free Report) last posted its earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share for the quarter, missing analysts' consensus estimates of $1.07 by ($0.42). National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The company had revenue of $63.32 million during the quarter, compared to the consensus estimate of $67.93 million. During the same quarter in the prior year, the business earned $1.08 EPS. The firm's revenue for the quarter was up 1.7% compared to the same quarter last year. As a group, equities research analysts predict that National Health Investors, Inc. will post 4.42 EPS for the current fiscal year.

National Health Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be paid a $0.90 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.60 annualized dividend and a dividend yield of 5.15%. National Health Investors's payout ratio is 123.71%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on NHI shares. Bank of America began coverage on shares of National Health Investors in a research report on Tuesday, September 24th. They set a "buy" rating and a $92.00 price objective on the stock. Wells Fargo & Company lowered National Health Investors from an "overweight" rating to an "equal weight" rating and increased their price target for the stock from $81.00 to $86.00 in a report on Tuesday, October 1st. StockNews.com cut National Health Investors from a "buy" rating to a "hold" rating in a research note on Tuesday, October 15th. Finally, Truist Financial upped their target price on National Health Investors from $65.00 to $78.00 and gave the stock a "hold" rating in a research report on Friday, August 30th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $76.33.

Check Out Our Latest Stock Analysis on National Health Investors

About National Health Investors

(Free Report)

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Further Reading

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

→ ⭕ [URGENT] Buy Alert just triggered (From Behind the Markets) (Ad)

Should you invest $1,000 in National Health Investors right now?

Before you consider National Health Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.

While National Health Investors currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines